1 active trials 1 recruiting 1 Phase 3 2 disease areas
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT05429632 | Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT | Adult Acute Myeloid Leukemia | Recruiting | 2026-07-17 |
Leukemia (1) · Acute Myeloid Leukemia (AML) (1)